title: Legal and economic perspectives concerning US government investigations of alleged off-label promotion by drug manufacturers.
authors.forename: Paul E
authors.initials: PE
authors.lastname: Kalb
authors.forename: Paul E
authors.initials: PE
authors.lastname: Greenberg
mesh_terms: D017277:Drug Approval / Q000331:legislation & jurisprudence; D004345:Drug Industry / Q000191:economics / Q000331:legislation & jurisprudence*; D004348:Drug Labeling / Q000191:economics / Q000331:legislation & jurisprudence*; D035082:Federal Government; D006801:Humans; D007880:Legislation, Drug; D040541:Marketing / Q000191:economics / Q000331:legislation & jurisprudence*; D014481:United States; D014486:United States Food and Drug Administration / Q000331:legislation & jurisprudence